Literature DB >> 22215480

Case report: Bone tumor of the scapula in a patient undergoing liver transplantation.

Zhen-Qi Ding1, Hai-Fang Zhang, Liang-Qi Kang, Mo Sha.   

Abstract

BACKGROUND: De novo malignancies are serious complications in the late postoperative period after liver transplantation. The most common de novo tumors are skin malignancies, posttransplantation lymphoproliferative disorder, tumors of the head and neck, and Kaposi's sarcoma. Such posttransplant de novo malignancies are apparently rarely found in bone. CASE DESCRIPTION: We describe a patient with a low-grade, aggressive fibrous histiocytoma of the scapula. The patient had undergone liver transplantation 6 years earlier. En bloc resection of the tumor and limb salvage was performed. At the 2-year followup the patient had no signs of local recurrence or metastatic spread; the patient had a Musculoskeletal Tumor Society (MSTS) score of 87. LITERATURE REVIEW: A literature review suggests the main predisposing factors to such malignancies are immunosuppression and its length of use. According to the literature, tumors apparently are rare in bone after liver transplantation, with no clearly documented cases. However, in the presence of such a finding, our study might be the first clearly documented case study of this kind of bone tumor. CLINICAL RELEVANCE: We describe a patient with a bone tumor after liver transplantation. Our literature review suggests liver transplantation and long-term immunosuppression played a role in this patient's tumor.

Entities:  

Mesh:

Year:  2012        PMID: 22215480      PMCID: PMC3293983          DOI: 10.1007/s11999-011-2236-9

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  16 in total

1.  De novo sarcomas in solid organ transplant recipients.

Authors:  T L Husted; J F Buell; M J Hanaway; J Trofe; T Beebe; T Gross; M R First; E S Woodle
Journal:  Transplant Proc       Date:  2002-08       Impact factor: 1.066

2.  Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre.

Authors:  Gonzalo Sapisochin; Itxarone Bilbao; Cristina Dopazo; Luis Castells; Jose Luis Lázaro; Roberto Rodríguez; Mireia Caralt; Laia Blanco; Joaquin Balsells; Ramón Charco
Journal:  Hepatol Int       Date:  2010-12-28       Impact factor: 6.047

3.  Risk factors for development of de novo neoplasia after liver transplantation.

Authors:  X Xiol; J Guardiola; S Menendez; C Lama; J Figueras; J Marcoval; T Serrano; J M Botargues; M Mañer; R Rota
Journal:  Liver Transpl       Date:  2001-11       Impact factor: 5.799

Review 4.  Incidence and risk factors for cancer after liver transplantation.

Authors:  Gonzalo Hernández Vallejo; Carlos Jiménez Romero; Juan Carlos de Vicente
Journal:  Crit Rev Oncol Hematol       Date:  2005-10       Impact factor: 6.312

Review 5.  Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review.

Authors:  Eric Chak; Sammy Saab
Journal:  Liver Int       Date:  2010-10       Impact factor: 5.828

Review 6.  Cancer incidence and risk factors after solid organ transplantation.

Authors:  Claire M Vajdic; Marina T van Leeuwen
Journal:  Int J Cancer       Date:  2009-10-15       Impact factor: 7.396

7.  Long-term probability of and mortality from de novo malignancy after liver transplantation.

Authors:  Kymberly D S Watt; Rachel A Pedersen; Walter K Kremers; Julie K Heimbach; William Sanchez; Gregory J Gores
Journal:  Gastroenterology       Date:  2009-09-18       Impact factor: 22.682

8.  Malignancy after liver transplantation: cumulative risk for development.

Authors:  E Marqués Medina; C Jiménez Romero; A Gómez de la Cámara; A Rota Bernal; A Manrique Municio; E Moreno González
Journal:  Transplant Proc       Date:  2009 Jul-Aug       Impact factor: 1.066

Review 9.  Sarcomas in organ allograft recipients.

Authors:  I Penn
Journal:  Transplantation       Date:  1995-12-27       Impact factor: 4.939

10.  De novo tumors are a major cause of late mortality after orthotopic liver transplantation.

Authors:  U Baccarani; G L Adani; D Serraino; D Lorenzin; M Gambato; A Buda; G Zanus; A Vitale; P Piselli; A De Paoli; V Bresadola; A Risaliti; P Toniutto; U Cillo; F Bresadola; P Burra
Journal:  Transplant Proc       Date:  2009-05       Impact factor: 1.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.